Aarti Industries Limited

NSE AARTIIND.NS

Aarti Industries Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2024: USD 4.16 M

Aarti Industries Limited Net Cash Used Provided By Financing Activities is USD 4.16 M for the year ending March 31, 2024, a -27.17% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Aarti Industries Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2023 was USD 5.72 M, a -93.61% change year over year.
  • Aarti Industries Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2022 was USD 89.46 M, a 6.60% change year over year.
  • Aarti Industries Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2021 was USD 83.92 M, a 218.22% change year over year.
  • Aarti Industries Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2020 was USD -70.98 M, a -159.22% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
SV Wall Street
NSE: AARTIIND.NS

Aarti Industries Limited

CEO Mr. Suyog Kalyanji Kotecha
IPO Date July 1, 2002
Location India
Headquarters 71, Udyog Kshetra
Employees 6,100
Sector Health Care
Industries
Description

Aarti Industries Limited manufactures and sells specialty chemicals and pharmaceuticals in India. It offers di chloro benzene, nitro chloro and nitro benzene, nitro toluenes, sulphur, and other organic and inorganic products that are used in the manufacture of intermediates with applications in agrochemicals, pharmaceuticals, polymer additives, fuel additives, FMCG, dyes, pigments, paints, printing inks, rubber chemicals, resins, and other speciality chemical applications. The company also provides active pharmaceutical ingredients, which have applications in anti-hypertensive, anti asthamatic, anti-cancer, anti thalassaemic, analgesic, ophthalmologic, and calcimimetics; central nervous system agents; and skin care and decongestant products. In addition, it offers intermediates; and xanthine derivatives, such as caffeine anhydrous, theophylline, aminophylline, acephylline piperazine, choline theophylline, doxofylline, DMAU, and theobromine derivatives, as well as contract manufacturing and research services. The company also exports its products to approximately 60 countries in North America, Europe, China, Japan, and internationally. Aarti Industries Limited was incorporated in 1984 and is headquartered in Mumbai, India.

Similar companies

DEEPAKNTR.NS

Deepak Nitrite Limited

USD 26.22

-0.23%

PIIND.NS

PI Industries Limited

USD 39.87

0.86%

ATUL.NS

Atul Ltd

USD 73.02

1.02%

NAVINFLUOR.NS

Navin Fluorine International Limited

USD 45.08

4.44%

VINATIORGA.NS

Vinati Organics Limited

USD 18.94

1.14%

StockViz Staff

January 31, 2025

Any question? Send us an email